Core Viewpoint - Haijia Medical (06078) shares rose over 4%, currently up 4.13% at HKD 13.35, with a trading volume of HKD 62.37 million [1] Financial Projections - The company expects revenue for 2025 to be approximately RMB 4.0–4.05 billion, representing a year-on-year decline of about 9% to 10% [1] - Net profit is projected to be around RMB 140–200 million, reflecting a year-on-year decrease of approximately 66% to 76%, primarily due to goodwill impairment [1] - Adjusted net profit is anticipated to be between RMB 450–490 million, indicating a year-on-year decline of about 19% to 25% [1] - Cash generated from operating activities is expected to be around RMB 940–1,000 million, showing a year-on-year increase of approximately 33% to 41% [1] Factors Influencing Financial Performance - The decline in revenue, net profit, and adjusted net profit is attributed to industry and macroeconomic impacts, as well as increased startup costs and depreciation for newly opened hospitals [1] - The decrease in net profit for the year ending December 31, 2025, is also significantly influenced by the goodwill impairment provision related to Etern Group Ltd. [1] - The company has conducted a careful assessment of its operational and financial performance, along with future business prospects, to determine the necessity and amount of the impairment and provision [1]
海吉亚医疗涨超4% 预计去年收入净利下跌 经营性现金流增超33%